Cover Image

List of approved drugs from ChEMBL

Fuente: Zenodo

Saved in:

Bibliographic Details
Main Author:	Durník, Robin
Format:	Recurso digital
Published:	Zenodo 2025
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

List of chemicals from TG-GATEs
by: Durník, Robin
Published: (2025)

List of chemicals from ECHA REACH
by: Durník, Robin
Published: (2025)

Democratizing Drug Discovery: A Scalable Open-Source Pipeline for Massive Multi-Target QSAR Modeling Using ChEMBL36
by: Zaliani, Andrea, et al.
Published: (2026)

Single-Cell Transcriptomic Identification of Drug Repurposing Candidates for Ankylosing Spondylitis via PBMC scRNA-seq and ChEMBL Target Screening
by: Ritschel, Glen Charles, et al.
Published: (2026)

Biological Data Resources at the EMBL-EBI
by: Rodrigo Lopez
Published: (2008)

FDA approves first immunotherapy drug for nasopharyngeal carcinoma
by: Mary Beth Nierengarten
Published: (2024)

Critical insights into the evolving drug‐approval process in China
by: Mina Nikanjam, et al.
Published: (2024)

FDA‐approved drugs featuring macrocycles or medium‐sized rings
by: Youlong Du, et al.
Published: (2025)

Diffuse midline gliomas get first FDA‐approved drug
by: Leah Lawrence
Published: (2025)

Legal analysis assails FDA's lowering of standards for drug approval
Published: (2026)

Discrepancy in accelerated approvals for cancer drugs in the United States and Europe
by: Mary Beth Nierengarten
Published: (2024)

FDA approves drug to treat neurologic manifestations of Hunter syndrome
Published: (2026)

Do drugs approved via expedited approval pathways have therapeutic advantages? A systematic review and meta‐analysis
by: Ashleigh Hooimeyer, et al.
Published: (2026)

Identification of aryl hydrocarbon receptor allosteric antagonists from clinically approved drugs
by: Farag E. S. Mosa, et al.
Published: (2024)

The mechanism of action and chemical synthesis of FDA newly approved drug molecules
by: Dan‐Dan Shen, et al.
Published: (2024)

Deployment and transcriptional evaluation of nitisinone, an FDA ‐approved drug, to control bed bugs
by: Marcos Sterkel, et al.
Published: (2025)

Novel drugs approved by the EMA, the FDA and the MHRA in 2024: A year in review
by: Stavros Topouzis, et al.
Published: (2025)

Postmarket safety communications on drugs approved in Japan: A 25‐year analysis
by: Yusuke Tanaka, et al.
Published: (2024)

Off-label use of psychotropic drugs beyond officially approved indications in Colombia
by: Paola Marcela Fletscher-Covaleda
Published: (2017)

In vitro and in silico investigation of FDA‐approved drugs to be repurposed against Alzheimer's disease
by: Didem Akkaya, et al.
Published: (2024)

In vitro effectivity of three approved drugs and their synergistic interaction against Leishmania infantum
by: Iman Fathy Abou-El-Naga
Published: (2020)

Study of trofinetide in Rett syndrome: Lessons from an approved drug for a severe neurodevelopmental disorder
by: Walter E. Kaufmann
Published: (2025)

2024 leucovorin paper retracted, drug pending FDA approval for cerebral folate deficiency
by: Alison Knopf
Published: (2026)

The demolition drug
by: Orwant, Robin
Published: (1998)

Cryptosporidiosis vaccine approved
by: Abby Webb
Published: (2024)

Policy position approved
Published: (2026)

Identification, validation, and characterization of approved and investigational drugs interfering with the SARS‐CoV‐2 endoribonuclease Nsp15
by: Spyros D. Chatziefthymiou, et al.
Published: (2025)

Status of oncology drugs with a conditional approval: A cross‐sectional comparison of the Food and Drug Administration and Health Canada
by: Joel Lexchin
Published: (2025)

FDA approves second‐line TROP2‐directed antibody–drug conjugate Dato‐DXd for EGFR ‐mutated NSCLC
by: Leah Lawrence
Published: (2025)

The US Food and Drug administration has approved resmetirom as the first drug to treat metabolic dysfunction‐associated steatohepatitis (MASH)
by: Iskandar Idris
Published: (2024)

Raw data with Ethical approval
by: Choukaife, Hazem
Published: (2025)

Swedish farmers' approval of nudges
by: Liesbeth Colen, et al.
Published: (2024)

State attachment and gubernatorial approval
by: Jonathan Winburn, et al.
Published: (2024)

Barriers and hurdles delaying governance approval for an ethically approved nationwide clinical trial in pancreatic cancer
by: Ariadna Recasens, et al.
Published: (2024)

Inside Back Cover: Flexibility‐Aided Orientational Self‐Sorting and Transformations of Bioactive Homochiral Cuboctahedron Pd 12 L 16 (Angew. Chem. Int. Ed. 37/2025)
by: Subhasis Chattopadhyay, et al.
Published: (2025)

Reshaping study design for faster extrapolation‐based drug approval in pediatric inflammatory bowel diseases: An ESPGHAN–NASPGHAN position paper
by: Dan Turner, et al.
Published: (2025)

Repurposing FDA‐approved drugs to target malaria through inhibition of dihydrofolate reductase in the folate biosynthesis pathway: A prospective approach
by: Kanika Verma, et al.
Published: (2024)

Accelerated approval of multiple myeloma therapies
by: Mary Beth Nierengarten
Published: (2024)

Iraqi voters approve new Constitution
Published: (2005)

BVA approves gene editing position
by: Josh Loeb
Published: (2024)